MarketsandMarkets

Mice Model Market (Microinjection, Embryonic Stem Cell) Worth $1,819.9 Million by 2018

The global mice model market is segmented on the basis of type, technology, disease, and mice model services

 
Repost This

Dallas, TX -- (SBWIRE) -- 02/07/2014 -- This report studies “Mice Model Market - By Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018”, The market is estimated at $1,115.2 million in 2013 and is expected to reach $1,819.9 million by 2018, growing at a CAGR of 10.3% from 2013 to 2018.
http://www.marketsandmarkets.com/Market-Reports/mice-model-market-1308.html

Early buyers will receive 10% customization on this report@ http://www.marketsandmarkets.com/requestCustomization.asp?id=1308

The global mice model market is categorized into four broad segments, namely, by type, by technology, by disease, and by service. The mice model market, by type, comprises of inbred, outbred, congenic/hybrid, surgically modified, knockout, and spontaneous mutant mice. The market for technology is segmented into microinjection, embryonic stem cell technique, virus/vector, nuclear transferase, genetically modified sperm, and others. By disease, the mice model market is segmented into diabetes, CNS, oncology, cardiovascular, immunology and inflammation, metabolism and regulation, and others. The market for mice model services is segmented into breeding, cryopreservation, quarantine, rederivation, genetic testing, model in-licensing, and other services (surgical and line rescue). The report also includes the mice care products market, which includes cages, feed, bedding, and others.

Ask for Free PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=1308

The expanding global biotechnology and pharmaceutical industries and increasing government investments, funds, and grants have stimulated the usage of advanced mice models in the biotechnology and pharmaceutical industries. Furthermore, research activities in the fields of cancer, HIV, and diabetes have increased the application areas of mice models. Various factors such as technological advancements, incessant rise in new product launches, and increasing number of conferences are propelling the growth of the mice model market.

The mice model market is marked by three major players contributing to approximately 75% of the mice model and services market. These players include The Jackson Laboratory (U.S.), Charles River Laboratories (U.S.), and Taconic Farms, Inc. (U.S.). The Jackson Laboratory—with its competitive pricing and huge inventory of mice models—accounts for the largest volume of mice sold to end users (approximately 3 million in 2012). However, the Charles River Laboratories is the leader in the mice model and services market as it is a for-profit distributor identity, which is in contrast to the non-profit distributor identity of The Jackson Laboratory.

The major players in the mice model market include Charles River Laboratories (U.S.), The Jackson Laboratory (U.S.), Taconic farms, Inc. (U.S.), genOway S.A. (France), Covance, Inc. (U.S.), Crescendo Biologics Limited (U.K.), Deltagen, Inc. (U.S.), Harbour Antibodies BV (The Netherlands), Harlan Laboratories, Inc. (U.S.), TransGenic, Inc. (U.S.), SAGE Labs (U.S.), inGenious Targeting Laboratory, Inc. (U.S.), Lexicon Pharmaceuticals, ImmunoGenes AG (Switzerland), Mirimus, Inc. (U.S.), and Ablexis LLC (U.S.).

Browse Related Reports:
Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/nerve-repair-regeneration-market-883.html

Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012 – 2017) - (Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases)
http://www.marketsandmarkets.com/Market-Reports/autologous-cell-therapy-market-837.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets